Invesaro

Stocks IDT Financial statements

Financial statements

IDT CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data IDT CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,4961,5021,5471,4091,3461,4471,3641,2391,2061,231
Cost of revenue1,2471,2761,3061,039882816785
Gross profit250226241325357390446
Research and development474850.651
Selling, general and administrative205188203204215218217243270288
Operating expenses1,4781,4861,5371,4021,3231,391265296325346
Operating income26.25.558.38-1.0117.95760.160.764.8100
Other non-operating income2.050.82-1.350.68-1.277.92-25.4-3.08-7.61-0.71
Pre-tax income29.57.628.10.4517.765.234.960.861.9106
Income tax4.11-2.022.90.12-3.7-31.75.8816.4-6.3524.7
Net income to minority interests1.841.460.990.2-0.010.421.983.873.815.05
Net income23.58.184.210.1321.496.52740.564.576.1
EBITDA46.727.331.221.638.374.878.280.985.1121
EPS, basic1.030.350.170.010.823.781.051.592.553.02
EPS, diluted1.030.350.170.010.813.701.031.582.543.01
Shares, basic (weighted)22.823.224.725.326.325.525.825.525.225.2
Shares, diluted (weighted)22.823.324.725.326.426.126.425.625.425.3
Dividend per share0.750.760.560.100.22

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents10490.37480.284.910798.4104165227
Short-term investments52.958.35.97
Receivables47.26570.758.144.246.639.532.142.244.9
Other current assets13.218.728.424.719.316.823.628.425.928.7
Total current assets339371329368322388363387423520
Property, plant and equipment87.38936.134.430.130.836.938.738.738.9
Lease right-of-use assets9.497.677.215.543.271.88
Goodwill11.211.311.311.212.914.926.426.526.326.5
Intangible assets0.840.50.54.23.967.589.618.26.295.06
Long-term investments1426.96.639.328.8311.77.439.876.526.66
Other non-current assets3.353.6610.511.68.9110.410.310.911.58.16
Total assets470519400444405513497511550626
Accounts payable29.84145.937.125.224.528.522.224.819.4
Accrued liabilities11712513012812612911711110397.3
Deferred revenue85.776.55542.540.142.336.535.330.427.7
Total current liabilities344363367389325339305294279293
Lease liabilities7.355.474.612.881.531.1
Other non-current liabilities1.21.081.311.081.391.236.593.352.661.69
Total liabilities345364368390334346316300284296
Paid-in capital396394294273277278296301304308
Retained earnings-154-163-173-161-139-42.9-15.824.786.6157
Treasury stock-115-83.3-85.6-51.7-56.2-60.4-102-115-126-144
Other comprehensive income-3.74-2.34-4.97-4.86-7.41-10.2-11.3-17.2-18.1-16.6
Shareholders' equity12414630.756.274.8165168194246305
Minority interests0.418.820.64-2.69-3.631.753.026.279.4713.8
Total equity12415531.353.671.1167171200256319
Total liabilities and equity470519400444405513497511550626

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income25.49.645.20.3321.496.92944.468.381.1
Depreciation and amortization20.521.722.822.620.417.818.120.120.421
Stock-based compensation2.683.743.582.243.861.491.934.527.43.07
Deferred income tax-3.812.33-6.17-1.08-3.92-334.2413.6-9.8316.2
Change in receivables0.62-18-6.677.5911.70.98-8.284.73-12.7-6.46
Change in payables-10.116.712.8-7.55-12.1-0.26-1.11-21-9.08-4.81
Cash from operations49.136.120.485.1-29.666.629.452.478.2127
Capital expenditures-18.4-22.9-20.6-18.7-16-16.8-21.9-22-18.9-20.8
Acquisitions-1.83-5.53-0.45-3.67-7.55
Purchases of investments-2-9.44-22.5-8.28-22.4-43.2-24.5-59.9-29.9-33.5
Sales and maturities of investments0.630.0241.56.316.4626.221.249.250.136.3
Cash from investing-16.5-39.6-1.64-26.2-32.5-44.1-33.8-33.5-0.75-20.7
Debt repaid-6.35
Stock issued24.913.30.280.690.140.170.17
Share buybacks-4.77-1.84-2.29-3.88-4.48-4.19-26.2-13.9-10.6-17.8
Dividends paid-17.4-17.9-13.9-2.54-5.55
Cash from financing-27.66.82-26.67.22-5.65-4.52-15.6-14.1-17.2-23.4
Exchange rate effect-5.820.29-0.96-12.211.77.66-17.44.39-3.583.48
Net change in cash-0.823.6-8.7754-5625.7-37.49.2656.686.4
Free cash flow30.713.1-0.1766.5-45.649.97.5330.459.3106
Interest paid0.350.290.090.190.390.490.460.540.430.11
Income taxes paid0.780.580.190.050.060.190.110.780.530.28

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to April 30, 2026; growth uses fiscal years. Valuation uses the share price of $67.46 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin37.4%Gross profit / revenue.
Operating margin8.6%Operating income / revenue.
EBITDA margin10.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin8.9%Pre-tax income / revenue.
Net margin6.4%Net income / revenue.
FCF margin4.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin6.1%Cash from operations / revenue.
Effective tax rate22.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)22.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)11.7%Net income / average total assets.
Return on invested capital (ROIC)59.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue4.3%Research and development expense / revenue.
SG&A / revenue23.9%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.8%Capital expenditures / revenue.
D&A / revenue1.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y2.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-3.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-1.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y14.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y11.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y55.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y18.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y41.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y42.7%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y15.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y25.9%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y18.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y41.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y28.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y18.5%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y43.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y30.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y62.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y62.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y79.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y141.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share growth, 1y120.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y23.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y22.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y32.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y13.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y9.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.92xCurrent assets / current liabilities.
Quick ratio0.83x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.70x(Cash + short-term investments) / current liabilities.
Liabilities / assets44.4%Total liabilities / total assets.
Working capital$284.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets3.8%(Goodwill + intangible assets) / total assets.
Tangible book value$331.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.83xRevenue / average total assets.
Fixed asset turnover31.1xRevenue / average property, plant and equipment.
Receivables turnover30.6xRevenue / average receivables.
Days sales outstanding12 days365 x average receivables / revenue.
Days payables7 days365 x average accounts payable / cost of revenue.
FCF conversion67.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow28.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.28Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$51.20Revenue / diluted weighted shares.
FCF per share$2.22Free cash flow / diluted weighted shares.
Operating cash flow per share$3.12Cash from operations / diluted weighted shares.
Book value per share$14.36Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$13.30Tangible book value / shares outstanding.
Cash per share$8.63(Cash + short-term investments) / shares outstanding.
Payout ratio7.7%Dividends paid / net income, when net income is positive.
Dividends / FCF11.3%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.68BShare price x shares outstanding.
Enterprise value$1.46BMarket cap + total debt - cash - short-term investments.
P/E20.5xMarket cap / net income. Only when net income is positive.
P/S1.32xMarket cap / revenue.
P/B4.69xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book5.06xMarket cap / tangible book value, when positive.
P/FCF30.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF21.6xMarket cap / cash from operations, when positive.
EV/Sales1.15xEnterprise value / revenue.
EV/EBIT13.3xEnterprise value / operating income, when both are positive.
EV/EBITDA11.1xEnterprise value / EBITDA, when both are positive.
EV/FCF26.4xEnterprise value / free cash flow, when both are positive.
FCF yield3.3%Free cash flow / market cap.
Earnings yield4.9%Net income / market cap (the inverse of P/E).
Dividend yield0.4%Dividends paid over the period / market cap.
Shareholder yield0.4%(Dividends paid + share buybacks) / market cap.
PEG0.48xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was IDT CORP's revenue in fiscal 2025?

IDT CORP reported revenue of $1.23B for fiscal 2025, 2.1% higher than the year before.

Was IDT CORP profitable in fiscal 2025?

Yes. Net income was $76.1M, a net margin of 6.2%.

How much free cash flow did IDT CORP generate in fiscal 2025?

Cash from operations of $127.1M minus capital expenditures of $20.8M left free cash flow of $106.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to IDT CORP